Press
Releases
10/9/2008 SenoRx Announces Third Quarter 2008 Webcast and Conference Call
9/19/2008 SenoRx Announces Three Abstracts Accepted for Presentation
9/15/2008 SenoRx to Present at UBS Global Life Sciences Conference
8/22/2008 SenoRx and Hologic Agree to Resume Proceedings in Lawsuit
8/12/2008 SenoRx Announces Second Quarter 2008
7/29/2008 SenoRx to Present at CanaccordAdams Conference
7/10/2008 SenoRx Announces Second Quarter 2008 Webcast and Conference Call
7/1/2008 SenoRx Receives Additional 510_K_ Clearance for its Contura MLB
6/24/2008 SenoRx Announces Court Grants Stay of Proceedings
6/6/2008 SenoRx Appoint A. Thomas Bender to Board of Directors
5/27/2008 SenoRx Annnounces Court Dismisses Unfair Competition Claims
5/13/2008 SenoRx Announces First Quarter 2008 Results
5/7/2008 SenoRx to Present at Two Investor Conferences in May
5/6/2008 SenoRx Appoints John Buhler as VP of Int'l Sales and Business Development
5/5/2008 SenoRx Receives Clearance for Modified Contura MLB Warning Label
4/29/2008 Court Denies Hologic Request for Preliminary Injunction
4/15/2008 SenoRx Announces First Quarter 2008 Conference Call
4/10/2008 SenoRx Announces CE Mark for SenoSonix
4/3/2008 SenoRx Launches Products in Additional Countries
2/19/2008 SenoRx Reports Yearend-Fourth Quarter 2007 Results_Final
2/1/2008 SenoRx Announces Fourth Quarter 2007 Conf Call
1/17/2008 SenoRx Launches Contura
1/11/2008 SenoRx Responds to Hologic Lawsuit
12/20/2007 SenoRx Provides 2008 Revenue Estimate
11/26/2007 SenoRx Announces Launch of VisiLoc Obturator
11/26/2007 SenoRx to Present at BMO Healthcare Conf
11/13/2007 SenoRx Announces Third Quarter 2007 Results
11/1/2007 SenoRx Announces Third Symposium-Contura
10/30/2007 SenoRx Named on Deloitte's 2007 Technology Fast 500
10/22/2007 SenoRx Launches Products in Ten Countries
10/17/2007 SenoRx Announces 510_k_ Clearance for SenoSonix
10/17/2007 SenoRx Announces Third Quarter 2007 Conference Call
10/15/2007 SenoRx Announces Second Symposium-Contura
8/14/2007 SenoRx Announces Second Quarter 2007 Results
7/26/2007 SenoRx to Present at Canaccord Adams Conference
7/16/2007 SenoRx Announces Second Quarter Conference Call
6/28/2007 SenoRx Announces First Uses of Balloon
6/21/2007 SENORX CEO TO BE INTERVIEWED LIVE ON MN1, ON FRIDAY, JUNE 22, AT 11:00 A.M. ET
6/21/2007 Paul Lubock featured in OC Register Article about SenoRx
6/19/2007 SenoRx Announces Additional Patent for Radiation Balloon
6/11/2007 SenoRx CEO Featured in Wall Street Interview
5/28/2007 SenoRx Named Outstanding Medical Device Company by AeA
5/23/2007 SenoRx Announces 510(k) Clearance for Multi-Lumen Radiation Balloon
5/16/2007 SenoRx Announces First Quarter 2007 Results
5/14/2007 SenoRx Appoints New Director
5/8/2007 SenoRx Announces Participation in Upcoming Investor Conferences
5/3/2007 SenoRx Announces First Quarter 2007 Conference Call
4/23/2007 SenoRx, Inc. Announces Exercise of Over-Allotment Option
3/28/2007 SenoRx, Inc. Announces Pricing of Initial Public Offering
1/22/2007 SenoRx Named 87th Fastest Growing Company on Deloitte's Fast 500
5/25/2006 SenoRx Successfully Settles Lawsuit
2/21/2006 SenoRx Launches New Breast Device
2/2/2006 Next Generation SenoRx Breast Biopsy System Available for use with MRI
1/18/2006 CEO Interview with WALLSTREETREPORTER
1/6/2006 SenoRx Granted New Patents for Partial Breast Radiation Balloon
1/4/2006 Surgical Benefits Conveyed by Gel Mark® Ultra Breast Biopsy Marking System
12/6/2003 New Technology Pass-through Reimbursement
12/4/2003 New Cancer Staging Device
4/4/2003 SenoRx Adds to Board of Directors
8/22/2002 510(k) Clearance for Single Step™ Biopsy Device
5/27/2002 Distribution Partnership with Japan
4/3/2002 Kim Blickenstaff Joins SenoRx Inc. BOD
2/5/2002 510(k) Clearance for Breast Biopsy Product
1/30/2002 John Erb Joins SenoRx Inc. Board of Directors
7/5/2001 SenoRx Completes Series C Funding
|
